|
1
|
Zhang L, Xu Z, Xu X, Zhang B, Wu H, Wang
M, Zhang X, Yang T, Cai J, Yan Y, et al: SALL4, a novel marker for
human gastric carcinogenesis and metastasis. Oncogene.
33:5491–5500. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang L, Chen X, Du Z, Li G, Chen M, Liang
G and Chen T: Curcumin suppresses gastric tumor cell growth via
ROS-mediated DNA polymerase gamma depletion disrupting cellular
bioenergetics. J Exp Clin Cancer Res. 36:472017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Hagen P, Hulshof MC, van Lanschot JJ,
Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ,
Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, et al: Preoperative
chemoradiotherapy for esophageal or junctional cancer. N Engl J
Med. 366:2074–2084. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun KX, Xia HW and Xia RL: Anticancer
effect of salidroside on colon cancer through inhibiting JAK2_STAT3
signaling pathway. Int J Clin Exp Pathol. 8:615–621.
2015.PubMed/NCBI
|
|
7
|
Zhao G, Shi A, Fan Z and Du Y: Salidroside
inhibits the growth of human breast cancer in vitro and in vivo.
Oncol Rep. 33:2553–2560. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Paterson I and Anderson EA: Chemistry. The
renaissance of natural products as drug candidates. Science.
310:451–453. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qi Z, Qi S, Ling L, Lv J and Feng Z:
Salidroside attenuates inflammatory response via suppressing
JAK2-STAT3 pathway activation and preventing STAT3 transfer into
nucleus. Int Immunopharmacol. 35:265–271. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guan S, Feng H, Song B, Guo W, Xiong Y,
Huang G, Zhong W, Huo M, Chen N, Lu J and Deng X: Salidroside
attenuates LPS-induced pro-inflammatory cytokine responses and
improves survival in murine endotoxemia. Int Immunopharmacol.
11:2194–2199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan XJ, Wang Y, Wang L and Zhu M:
Salidroside induces apoptosis and autophagy in human colorectal
cancer cells through inhibition of PI3K/Akt/mTOR pathway. Oncol
Rep. 36:3559–3567. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang L, Ding W, Sun H, Zhou Q, Huang J,
Li X, Xie Y and Chen J: Salidroside protects PC12 cells from
MPP(+)-induced apoptosis via activation of the PI3K/Akt pathway.
Food Chem Toxicol. 50:2591–2597. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Z, Li X, Simoneau AR, Jafari M and Zi
X: Rhodiola rosea extracts and salidroside decrease the growth of
bladder cancer cell lines via inhibition of the mTOR pathway and
induction of autophagy. Mol Carcinog. 51:257–267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Forman HJ, Torres M and Fukuto J: Redox
signaling. Mol Cell Biochem. 234–235:49–62. 2002. View Article : Google Scholar
|
|
15
|
Storz P: Reactive oxygen species in tumor
progression. Front Biosci. 10:1881–1896. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Li JZ, Lu AX, Zhang KF and Li BJ:
Anticancer effect of salidroside on A549 lung cancer cells through
inhibition of oxidative stress and phosphor-p38 expression. Oncol
Lett. 7:1159–1164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Okon IS and Zou MH: Mitochondrial ROS and
cancer drug resistance: Implications for therapy. Pharmacol Res.
100:170–174. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Budina-Kolomets A, Webster MR, Leu JI,
Jennis M, Krepler C, Guerrini A, Kossenkov AV, Xu W, Karakousis G,
Schuchter L, et al: HSP70 inhibition limits FAK-dependent invasion
and enhances the response to melanoma treatment with BRAF
inhibitors. Cancer Res. 76:2720–2730. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ciocca DR and Calderwood SK: Heat shock
proteins in cancer: Diagnostic, prognostic, predictive, and
treatment implications. Cell Stress Chaperones. 10:86–103. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun C, Wang Z, Zheng Q and Zhang H:
Salidroside inhibits migration and invasion of human fibrosarcoma
HT1080 cells. Phytomedicine. 19:355–363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sutton P, Borgia JA, Bonomi P and Plate
JM: Lyn, a Src family kinase, regulates activation of epidermal
growth factor receptors in lung adenocarcinoma cells. Mol Cancer.
12:762013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Summy JM and Gallick GE: Treatment for
advanced tumors: SRC reclaims center stage. Clin Cancer Res.
12:1398–1401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ablin RJ, Owen S and Jiang WG: Prostate
transglutaminase (TGase-4) induces epithelial-to-mesenchymal
transition in prostate cancer cells. Anticancer Res. 37:481–487.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lv C, Huang Y, Liu ZX, Yu D and Bai ZM:
Salidroside reduces renal cell carcinoma proliferation by
inhibiting JAK2/STAT3 signaling. Cancer Biomark. 17:41–47. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan L, Lin B, Gao L, Gao S, Liu C, Wang C,
Wang Y, Zhang S and Iwamori M: Lewis (y) antigen overexpression
increases the expression of MMP-2 and MMP-9 and invasion of human
ovarian cancer cells. Int J Mol. Sci. 11:4441–4452. 2010.
|
|
26
|
Rajoria S, Suriano R, George A, Shanmugam
A, Schantz SP, Geliebter J and Tiwari RK: Estrogen induced
metastatic modulators MMP-2 and MMP-9 are targets of
3,3′-diindolylmethane in thyroid cancer. PloS One. 6:e158792011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lai WW, Hsu SC, Chueh FS, Chen YY, Yang
JS, Lin JP, Lien JC, Tsai CH and Chung JG: Quercetin inhibits
migration and invasion of SAS human oral cancer cells through
inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling
pathways. Anticancer Res. 33:1941–1950. 2013.PubMed/NCBI
|
|
28
|
Braicu EI, Gasimli K, Richter R, Nassir M,
Kümmel S, Blohmer JU, Yalcinkaya I, Chekerov R, Ignat I, Ionescu A,
et al: Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring
response to adjuvant radiochemotherapy in patients with primary
cervical cancer-results of a companion protocol of the randomized
NOGGO-AGO phase III clinical trial. Anticancer Res. 34:385–391.
2014.PubMed/NCBI
|
|
29
|
Liu L, Zhang J, Yang X, Fang C, Xu H and
Xi X: SALL4 as an epithelial-mesenchymal transition and drug
resistance inducer through the regulation of c-Myc in endometrial
cancer. PloS One. 10:e01385152015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Weinberg RA: Mechanisms of malignant
progression. Carcinogenesis. 29:1092–1095. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin SY, Chang HH, Lai YH, Lin CH, Chen MH,
Chang GC, Tsai MF and Chen JJ: Digoxin suppresses tumor malignancy
through inhibiting multiple Src-related signaling pathways in
non-small cell lung cancer. PloS One. 10:e01233052015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Smith AL, Iwanaga R, Drasin DJ, Micalizzi
DS, Vartuli RL, Tan AC and Ford HL: The miR-106b-25 cluster targets
Smad7, activates TGF-β signaling and induces EMT and tumor
initiating cell characteristics downstream of Six1 in human breast
cancer. Oncogene. 31:5162–5171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu J, Bao J, Hao J, Peng Y and Hong F:
HSP70 inhibits high glucose-induced Smad3 activation and attenuates
epithelial-to-mesenchymal transition of peritoneal mesothelial
cells. Mol Med Rep. 10:1089–1095. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang J, Zhu T, Liu X, Zhang L, Yang Y,
Zhang J and Guο M: Heat shock protein 70 protects rat peritoneal
mesothelial cells from advanced glycation end-products-induced
epithelial-to-mesenchymal transition through mitogen activated
protein kinases/extracellular signal-regulated kinases and
transforming growth factor-β/Smad pathways. Mol Med Rep.
11:4473–4481. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mustafi Banerjee S, Chakraborty PK and
Raha S: Modulation of Akt and ERK1/2 pathways by resveratrol in
chronic myelogenous leukemia (CML) cells results in the
downregulation of Hsp70. PloS One. 5:e87192010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fang X, Jiang Y, Feng L, Chen H, Zhen C,
Ding M and Wang X: Blockade of PI3K/AKT pathway enhances
sensitivity of Raji cells to chemotherapy through down-regulation
of HSP70. Cancer Cell Int. 13:482013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mustafi Banerjee S, Chakraborty PK, Dey RS
and Raha S: Heat stress upregulates chaperone heat shock protein 70
and antioxidant manganese superoxide dismutase through reactive
oxygen species (ROS), p38MAPK, and Akt. Cell Stress Chaperones.
14:579–589. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Diao J, Yang X, Song X, Chen S, He Y, Wang
Q, Chen G, Luo C, Wu X and Zhang Y: Exosomal Hsp70 mediates
immunosuppressive activity of the myeloid-derived suppressor cells
via phosphorylation of Stat3. Med Oncol. 32:4532015. View Article : Google Scholar : PubMed/NCBI
|
